SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT05445154 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Newly Diagnosed Acute Myeloid Leukemia (AML)

Interventions

DRUG: SKLB1028 Dose Escalation

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.